Not Signed In - Data Show Treatment With Remicade(R) Reduced Hospitalizations For Ulcerative Colitis Patients By Half
Tue, 24 Oct 2006 07:00 AM EST
... Patients with ulcerative colitis (UC) treated with REMICADE(R) (infliximab) had an approximate 50 percent reduction in mean number of hospitalizations per year compared with placebo, according to an analysis of long-term data from a Phase 3 clinical trial (Active Ulcerative Colitis Trial 1, ACT 1) presented at the American College of Gastroenterology (ACG) meeting. [click link for full article] ...
Related Topics
- Ulcerative Colitis
- Infliximab
- Colitis
- Data & Statistics
- Data Analysis
- Seizures (in about half of patients)
- Crohn's Disease
- National Data
- Approximately one-half of patients with small tumors will get back useful hearing in the affected ear after surgery.
- Gingivitis
- Collagenous Colitis
- Ankylosing Spondylitis
- Mining
- Mesalamine Oral
- Frostbite
- Lymphocytic Colitis
- Reduced intellect (sometimes)
- Reduced life span
- Reduced lung function
- Reduced communication skills (sometimes)
email this page
print this page
bookmark this page
feedback on this page
